Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)

Clinical trial NCT01101035 · COMPLETED

Trial details

NCT number: NCT01101035
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2010-04-23
Primary completion: 2017-05-15
Enrollment: 6198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.